A Real-world Study of Inebilizumab for Neuromyelitis Optica Spectrum Disorders (P9-1.008)
This study aimed to evaluate the real-world effectiveness and safety of inebilizumab for patients with AQP4-IgG positive neuromyelitis optica spectrum disorders (NMOSD).
Authors
- Hongbo Liu (ORCID: https://orcid.org/0000-0002-0733-8616)
- Ao Shen (ORCID: https://orcid.org/0009-0004-3117-9362)
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211090
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00